Search Results - "Drost, Rinske"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
  2. 2

    BRCA1 RING Function Is Essential for Tumor Suppression but Dispensable for Therapy Resistance by Drost, Rinske, Bouwman, Peter, Rottenberg, Sven, Boon, Ute, Schut, Eva, Klarenbeek, Sjoerd, Klijn, Christiaan, van der Heijden, Ingrid, van der Gulden, Hanneke, Wientjens, Ellen, Pieterse, Mark, Catteau, Aurelie, Green, Pete, Solomon, Ellen, Morris, Joanna R., Jonkers, Jos

    Published in Cancer cell (13-12-2011)
    “…Hereditary breast cancers are frequently caused by germline BRCA1 mutations. The BRCA1 C61G mutation in the BRCA1 RING domain is a common pathogenic missense…”
    Get full text
    Journal Article
  3. 3

    Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin by Evers, Bastiaan, Drost, Rinske, Schut, Eva, de Bruin, Michiel, van der Burg, Eline, Derksen, Patrick W B, Holstege, Henne, Liu, Xiaoling, van Drunen, Ellen, Beverloo, H Berna, Smith, Graeme C M, Martin, Niall M B, Lau, Alan, O'Connor, Mark J, Jonkers, Jos

    Published in Clinical cancer research (15-06-2008)
    “…Purpose: To assess efficacy of the novel, selective poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor AZD2281 against newly established BRCA2-deficient mouse…”
    Get full text
    Journal Article
  4. 4

    Selected Alkylating Agents Can Overcome Drug Tolerance of G0-like Tumor Cells and Eradicate BRCA1-Deficient Mammary Tumors in Mice by Pajic, Marina, Blatter, Sohvi, Guyader, Charlotte, Gonggrijp, Maaike, Kersbergen, Ariena, Küçükosmanoğlu, Aslι, Sol, Wendy, Drost, Rinske, Jonkers, Jos, Borst, Piet, Rottenberg, Sven

    Published in Clinical cancer research (15-11-2017)
    “…Abstract Purpose: We aimed to characterize and target drug-tolerant BRCA1-deficient tumor cells that cause residual disease and subsequent tumor relapse…”
    Get full text
    Journal Article
  5. 5

    Challenging Future Generations: A Qualitative Study of Students' Attitudes toward the Transition to Animal-Free Innovations in Education and Research by Andreoli, Lara, Vlasblom, Ronald, Drost, Rinske, Meijboom, Franck L B, Salvatori, Daniela

    Published in Animals (Basel) (24-01-2023)
    “…In 2016, the Dutch government declared its commitment to phasing out animal experiments by 2025. Although a high number of animal experiments are still…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Selected Alkylating Agents Can Overcome Drug Tolerance of G 0 -like Tumor Cells and Eradicate BRCA1-Deficient Mammary Tumors in Mice by Pajic, Marina, Blatter, Sohvi, Guyader, Charlotte, Gonggrijp, Maaike, Kersbergen, Ariena, Küçükosmanoğlu, Aslι, Sol, Wendy, Drost, Rinske, Jonkers, Jos, Borst, Piet, Rottenberg, Sven

    Published in Clinical cancer research (15-11-2017)
    “…We aimed to characterize and target drug-tolerant BRCA1-deficient tumor cells that cause residual disease and subsequent tumor relapse. We studied responses to…”
    Get full text
    Journal Article
  11. 11

    A high-throughput functional complementation assay for classification of BRCA1 missense variants by Bouwman, Peter, van der Gulden, Hanneke, van der Heijden, Ingrid, Drost, Rinske, Klijn, Christiaan N, Prasetyanti, Pramudita, Pieterse, Mark, Wientjens, Ellen, Seibler, Jost, Hogervorst, Frans B L, Jonkers, Jos

    Published in Cancer discovery (01-10-2013)
    “…Mutations in BRCA1 and BRCA2 account for the majority of hereditary breast and ovarian cancers, and therefore sequence analysis of both genes is routinely…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression by Bouwman, Peter, Drost, Rinske, Klijn, Christiaan, Pieterse, Mark, Gulden, Hanneke van der, Song, Ji-Ying, Szuhai, Karoly, Jonkers, Jos

    Published in The Journal of pathology (01-05-2011)
    “…PALB2 interacts with BRCA1 and BRCA2 in supercomplexes involved in DNA repair via homologous recombination. Heterozygous germline mutations in PALB2 confer a…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Each of the four intracellular cysteines of CD36 is essential for insulin- or AMP-activated protein kinase-induced CD36 translocation by van Oort, Masja M., Drost, Rinske, Janβen, Linda, Van Doorn, Jan M., Kerver, Jana, Van der Horst, Dick J., Luiken, Joost J. F. P., Rodenburg, Kees (C.) W.

    Published in Archives of physiology and biochemistry (01-02-2014)
    “…Abstract Stimulation of cellular fatty acid uptake by induction of insulin signalling or AMP-kinase (AMPK) activation is due to translocation of the fatty…”
    Get full text
    Journal Article
  18. 18